Study of Effect of topical piroxicam or lidocaine in reducing pain during the ESWL and compared with intravenous injection of pethidine alone

Study of Effect of intravenous injection of pethidine plus piroxicam or lidocaine gel topical in reducing pain during the ESWL and comparison with intravenous injection of pethidine alone

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT138811043156N1

Enrollment

159

Registered

2010-12-29

Start date

2009-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain during ESWL. Calculus of kidney

Interventions

Intervention 1: petidin (IV) 25 mg + lidokaein gel. Intervention 2: petidin (IV)25 mg + piroxicam gel. Intervention 3: petidin (IV) 25 mg.

petidin (IV) 25 mg + lidokaein gel

petidin (IV)25 mg + piroxicam gel

petidin (IV) 25 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion : want to participate in the plan- absence severe hydronephrosis Exclusion: Presence severe hydronephrosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: immediatly after ESWL. Method of measurement: McGill Questionnaire during ESWL procedure.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr.moazeni bistgani mohammad

shahrekord university of medical sceinces

drmoazeni@skums.ac.ir+98 38 1222 4445

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026